Total Reports
41
Below-median volume
Breed profile · FDA CVM July 2026 extract
Adverse-event filings for Belgian Draft, also called Brabant or Brabants trekpaard (Horse) in the FDA Center for Veterinary Medicine openFDA extract. Browse horse breeds, reactions, and outcomes below.
By recorded gender -- every report on file for Belgian Draft, also called Brabant or Brabants trekpaard, no filtering.
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Belgian Draft, also called Brabant or Brabants trekpaard ranks #289 of 510 by total reports (41). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Belgian Draft, also called Brabant or Brabants trekpaard has 41 reports now versus 40 in that prior snapshot: 1 more (2.5%).
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Belgian Draft, also called Brabant or Brabants trekpaard changesTotal Reports
41
Below-median volume
Deaths Reported
5
of 41 reports
Death-coded share of reports
12.2%
12.2% death-coded
Avg Age at Report
13.6 yr
332.6 kg avg weight
12.2% of 41 belgian draft, also called brabant or brabants trekpaard reports involved a death outcome.
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
| Year | Reports | Trend |
|---|---|---|
| 2010 | 1 | |
| 2012 | 2 | |
| 2013 | 5 | |
| 2014 | 3 | |
| 2015 | 4 | |
| 2016 | 7 | |
| 2017 | 3 | |
| 2018 | 2 | |
| 2019 | 3 | |
| 2020 | 2 | |
| 2021 | 2 | |
| 2023 | 2 | |
| 2024 | 2 | |
| 2025 | 2 | |
| 2026 | 1 | |
Signature read: Belgian Draft, also called Brabant or Brabants trekpaard's 12.2% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Belgian Draft, also called Brabant or Brabants trekpaard sits at #289 of 510 by report volume among all breeds and #26 of 55 among horse breeds, with 41 reports and 5 (12.2%) death-coded. Mean age at report: 13.6 years, average weight 332.6 kg (733.4 lbs).
Top reported signs: Lack of efficacy - NOS (7), Swollen mouth (4), Abdominal pain (3). Most-referenced drug: Pergolide Mesylate (7 reports), followed by Firocoxib (5) and Omeprazole (5).
Outcome coding on 39 status-recorded reports is dominated by Outcome Unknown (43.6%). Annual submissions ranged 1-2,026 across 15 years on file.
Showing 6 of 54 horse breeds in our dataset, ranked by closest report volume.
Two openFDA-derived peer sets for Belgian Draft, also called Brabant or Brabants trekpaard, both outside the Horse family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Nearest other-species breeds by reported average weight (332.6 kg here).
What to do with this horse
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →